Keywords: ares-serono, 1sr, qtr, net, income, leaps, swiss
Ares-Serono 1sr qtr net income leaps 39.2%
Article | 28 April 2000
Swiss company Ares-Serono achieved net income of $52.5 million for thefirst quarter of 2000, an increase of 39.2% over the like, year-earlier quarter, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
